Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have had, or are scheduled to have, a blood vessel procedure on your legs (either open surgery or a less invasive procedure) because of poor blood flow, either sudden or long-term
- You have been taking a type of medication called an SGLT2 inhibitor (also known as "flozins," such as empagliflozin, dapagliflozin, or canagliflozin) for at least 3 months before the procedure, or you start taking one right after the procedure — this applies only to one group in the trial; the reason you were prescribed this medication (kidney disease, heart problems, or diabetes) does not matter
- Your health outcomes can be followed up for at least 30 days and up to 1 year after the procedure
Who may not be able to join:
- Your blood vessel procedure is needed because of a physical injury (such as trauma), rather than poor blood flow
- You need an amputation for a reason other than poor blood flow — for example, due to cancer, nerve damage, or injury without any associated poor blood flow
- At the time you leave the hospital, you have another blood vessel procedure planned that is not related to your legs — for example, a procedure on the heart or neck arteries
- At the time you leave the hospital, you are already planned to have an amputation or a repeat operation on the same leg due to poor blood flow
- At the time you leave the hospital, you are already planned to have another major surgery that carries a high risk to your heart or blood vessels
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Edyta Sutkowska, Ph.D, Wroclaw Medical University
Phone: 48503077016
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MACE (Major Adverse Cardiovascular Events) and MALE (Major Adverse Limb Events)-Number of Participants Experiencing MACEor MALE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.